Women and the metabolic syndrome: An overview of its peculiarities

Puerto Rico Health Sciences Journal

Volumn 27, Issue 3, 2008, Pages 190-195

  Allende Vigo, Myriam Z ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Cardiovascular disease in women; Insulin resistance; Risk factors in metabolic syndrome; Women with metabolic syndrome

Indexed keywords

FEMALE; HUMAN; METABOLIC SYNDROME X; OBESITY; OVARY POLYCYSTIC DISEASE; REVIEW; SEX DIFFERENCE;

FEMALE; HUMANS; METABOLIC SYNDROME X; OBESITY; POLYCYSTIC OVARY SYNDROME; SEX FACTORS;

EID: 58149110969     PISSN: 07380658     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Steinbaum, S. The Metabolic Syndrome: An Emerging Health Epidemic in Women. Progr Cardiovasc Dis 2004;464;321-336.
2. Prevalence of Heart Disease United States. MMWR 2007;56:113-118.
3. American Heart Association Heart and Stroke Statistical update Available from: URL: http://www.americanheart.org.
4. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on the Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
5. World Health Organization definition, diagnosis and classification of diabetes mellitus and its complications. 1999 Report of a WHO consultation.
6. Ford ES, Giles WH, Dietz WH. Prevalence of the Metabolic Syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287;356-359.
7. Ford ES, Giles WH, Dietz WH. Prevalence of the Metabolic Syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287;356-359.
8. Rabelo M, Ramírez M. Association between the Polycystic Ovarian Syndrome and the Metabolic Syndrome in Puerto Rico. P R Health Sci J; 2005;24:203-206.
9. Gomez M, Ramírez M, et al. Prevalence of the Metabolic Syndrome among a Determined Puerto Rican Population. P R Health Sci J 2005;25:111-116.
10. Haddock L, Pérez C, et al. Prevalence of the Metabolic Syndrome in a Female population 50 years and older in San Juan, Puerto Rico, 2002-2003. Diabetes 2004;53(Suppl 2):A243:994.
11. Zablotsky D, Mack K. Changes in Obesity Prevalence among Women aged 50 Years and Older: results from the Behavioral Risk Factor Surveillance System: 1990-2000 Res Aging 2004;26;1314-1330.
12. Heart Disease and stroke statistics Unpublished data Available from: URL: http://www.americanheart.org.
13. Sanchez-Torres R, Delgado-Osorio H. The Metabolic Syndrome and its Cardiovascular Manifestations. Bol Asoc Med PR 2005;97:271-280.
14. Fitzgerald N, Himmelgreen GD, et al. Acculturation, socioeconomic status, obesity and lifestyle factors among low-income Puerto Rican Women in Connecticut, U.S., 1998-1999. Rev Panam Sal Pub 2006;19:306-313.
15. Lorenzo C, Okoloise M, et al. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio Heart Study. Diabetes Care 2003;26;3153-3159.
16. Gupta, A. New-Onset Diabetes New Analysis of the Blood Pressure Lowering Arm of ASCOT (ASCOT-BPLA) European Society of Cardiology 2006 World Congress.
17. Bittner V. Perspectives on Dyslipidemia and Coronary Heart Disease in Women. J Amer Coll Cardiol 2005;l46:1628-1635.
18. Quyyumi A. Women and Ischemic Heart Disease Pathophysiologic Implications from the Women?s Ischemia Syndrome Evaluation (WISE): Study and future Research Steps. J Am Coll Cardiol 2004;l47:(Suppl S);66-71.
19. Marroquin O, Kip K, et al. Metabolic Syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women. Circulation 2004;109;714-721.
20. Kipp K, Marroquin O. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women, a report from the Women?s Ischemia Syndrome Evaluation (WISE) Study. Circulation 2004;109:706-713.
21. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin NEJM 2002;346:393-403.
22. The DREAM Trial investigators Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial. Lancet 2006;368:1096-1105.
23. Carr M. The Emergence of the Metabolic Syndrome with Menopause. JCEM 2003;88:2404-2411.
24. Knoop, Robert H. Risk Factors for Coronary Artery Disease in Women. Am J Cardiol 2002;89:28E-34E.
25. Gordon DJ, Probstfield JL, Garrison RJ, et al. High Density lipoprotein cholesterol and cardiovascular disease, Four Prospective American Studies. Circulation 1989;79;8-26.
26. Garber AJ. The Metabolic Syndrome. Med Clin N Am 2004;88:837-846.
27. Collins R, Armitage J, et al. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomized placebo-controlled trial. Lancet 2003;361:2005-2016.